Olanzapine's Anxiolytic Effects

Efficacy and Mechanism

• The American College of Clinical Pharmacology suggests that olanzapine is an antagonist of multiple receptors involved in anxiety, including muscarinic acetylcholine, dopaminergic, histaminergic, and serotonergic receptors, giving it a broader pharmacological profile for anxiolytic effects 1

Dosage and Administration

• The National Comprehensive Cancer Network recommends starting olanzapine at 2.5-10 mg/day at bedtime, with a maximum dose of 10 mg/day for control of agitation and psychotic symptoms 3
• The National Comprehensive Cancer Network also recommends starting risperidone at 0.25-0.5 mg/day at bedtime, with a maximum dose of 2-3 mg/day, considering that doses ≥2 mg/day increase the risk of extrapyramidal symptoms 3

Safety Considerations

• The American Geriatrics Society advises that olanzapine requires particular caution in the elderly due to the risk of death in patients with psychosis related to dementia (black box warning), type 2 diabetes, and hyperglycemia 1
• The American Gastroenterological Association recommends monitoring weight gain with olanzapine, particularly in patients with obesity or metabolic syndrome 4

Practical Recommendations

• The American Psychiatric Association suggests that for anxiolytic effects in the context of psychotic disorders, olanzapine represents a superior choice due to its greater efficacy on depressive/anxious symptoms and lower incidence of extrapyramidal effects that can exacerbate anxiety 4